Double blind placebo controlled trial of steroids in Bacterial Meningitis

ISRCTN ISRCTN42986828
DOI https://doi.org/10.1186/ISRCTN42986828
Protocol serial number 061330
Sponsor University of Oxford (UK)
Funder The Wellcome Trust (UK) (grant ref: 061330)
Submission date
22/07/2005
Registration date
22/07/2005
Last edited
28/10/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jeremy Farrar
Scientific

Hospital for Tropical Diseases
The Hospital for Tropical Diseases
Oxford University Clinical Research
190 Ben Ham Tu
Ho Chi Minh City
5
Viet Nam

Phone +84 8 8362225
Email jfarrar@oucru.org

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleDouble blind placebo controlled trial of steroids in Bacterial Meningitis
Study acronymBM Study
Study objectivesTo investigate the effects of dexamethazone on the course and outcome of Bacterial Meningitis (BM) in adults in Viet Nam.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBacterial meningitis
InterventionDouble blind randomised controlled trial. The intervention will be dexamethasone.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Dexamethazone
Primary outcome measure(s)

Mortality

Key secondary outcome measure(s)

No secondary outcome measures

Completion date01/01/2000

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteria1. The treating physician believes the diagnosis to be BM
2. History less than ten days (unless still Serebrospinal Fluid [CSF] evidence of bacteria)
3. CSF white cell count more than 50 with more than 50% neutrophils
4. CSF glucose less than 50% of blood glucose
Key exclusion criteria1. Chest X-Ray (CXR) shows evidence of possible Tuberculosis (TB)
2. History is longer than ten days
3. History of hypersensitivity to beta-lactam antibiotics
4. Known severe liver or renal impairment
5. Patients in whom the physician believes corticosteroids are contraindicated e.g. uncontrolled diabetes, gastro-intestinal bleeding etc.
6. Pre-existing severe neurological disability
7. Pregnancy within the first trimester
Date of first enrolment01/11/1996
Date of final enrolment01/01/2000

Locations

Countries of recruitment

  • Viet Nam

Study participating centre

Hospital for Tropical Diseases
Ho Chi Minh City
5
Viet Nam

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 21/10/2004 Yes No
Results article 13/12/2007 Yes No

Editorial Notes

28/10/2022: Internal review.